FDA Inspection 1119867 — American Red Cross Blood Services

American Red Cross Blood Services — FEI 2076545

The FDA completed an inspection of American Red Cross Blood Services on Feb 24, 2020 in Santa Ana, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection details

Classification
No Action Indicated (NAI)
End Date
Feb 24, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Santa Ana, CA (United States)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.